Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 2
2005 5
2006 3
2007 2
2008 3
2009 2
2010 1
2011 6
2012 4
2013 3
2014 1
2015 1
2016 1
2019 2
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Lancet. 2019 Apr 6;393(10179):1440-1452. doi: 10.1016/S0140-6736(18)33137-4. Epub 2019 Feb 8. Lancet. 2019. PMID: 30739743 Free PMC article.
In vitro toxicity assessment of oral nanocarriers.
Ciappellano SG, Tedesco E, Venturini M, Benetti F. Ciappellano SG, et al. Among authors: venturini m. Adv Drug Deliv Rev. 2016 Nov 15;106(Pt B):381-401. doi: 10.1016/j.addr.2016.08.007. Epub 2016 Aug 17. Adv Drug Deliv Rev. 2016. PMID: 27544694 Review.
ATAC trial update.
Del Mastro L, Venturini M. Del Mastro L, et al. Among authors: venturini m. Lancet. 2005 Apr 2-8;365(9466):1225; author reply 1225-6. doi: 10.1016/S0140-6736(05)74802-9. Lancet. 2005. PMID: 15811447 No abstract available.
Herceptin in elderly patients.
Bighin C, Stevani I, Venturini M. Bighin C, et al. Among authors: venturini m. Tumori. 2002 Jan-Feb;88(1 Suppl 1):S37-8. doi: 10.1177/030089160208800111. Tumori. 2002. PMID: 11989920 No abstract available.
Improving Quality in Nanoparticle-Induced Cytotoxicity Testing by a Tiered Inter-Laboratory Comparison Study.
Nelissen I, Haase A, Anguissola S, Rocks L, Jacobs A, Willems H, Riebeling C, Luch A, Piret JP, Toussaint O, Trouiller B, Lacroix G, Gutleb AC, Contal S, Diabaté S, Weiss C, Lozano-Fernández T, González-Fernández Á, Dusinska M, Huk A, Stone V, Kanase N, Nocuń M, Stępnik M, Meschini S, Ammendolia MG, Lewinski N, Riediker M, Venturini M, Benetti F, Topinka J, Brzicova T, Milani S, Rädler J, Salvati A, Dawson KA. Nelissen I, et al. Among authors: venturini m. Nanomaterials (Basel). 2020 Jul 22;10(8):1430. doi: 10.3390/nano10081430. Nanomaterials (Basel). 2020. PMID: 32707981 Free PMC article.
Temsirolimus in patients with renal cancer on hemodialysis.
Lunardi G, Vannozzi MO, Armirotti A, Nicodemo M, Venturini M, Cavallini L. Lunardi G, et al. Among authors: venturini m. J Clin Oncol. 2008 Dec 1;26(34):5652-3; author reply 5653-4. doi: 10.1200/JCO.2008.19.3144. Epub 2008 Nov 3. J Clin Oncol. 2008. PMID: 18981458 No abstract available.
40 results